A1 Refereed original research article in a scientific journal

Editor's Choice – European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins




AuthorsKoelemay, Mark J.; Geelkerken, Robert H.; Kärkkäinen, Jussi; Leone, Nicola; Antoniou, George A.; de Bruin, Jorg L.; Gombert, Alexander; Gottsätter, Anders; Iborra, Elena; Ronchey, Sonia; Spanos, Konstantinos; van den Berg, Jos C.; Wipper, Sabine; Bastos Gonçalves, Frederico; Björck, Martin; Coscas, Raphaël; Lepidi, Sandro; Resch, Timothy A.; Ricco, Jean-Baptiste; Tulamo, Riikka; Wanhainen, Anders; Corcos, Olivier; Huber, Thomas S.; Oberhuber, Alexander; Blaser, Annika Reintam; Tolonen, Matti

PublisherElsevier BV

Publication year2025

Journal:European Journal of Vascular and Endovascular Surgery

Volume70

Issue2

First page 153

Last page218

ISSN1078-5884

eISSN1532-2165

DOIhttps://doi.org/10.1016/j.ejvs.2025.06.010

Web address https://doi.org/10.1016/j.ejvs.2025.06.010

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/500037866


Abstract

Objective: The European Society for Vascular Surgery (ESVS) has developed clinical practice guidelines for the care of patients with diseases of the mesenteric and renal arteries and veins, in succession to the first 2017 guidelines, with the aim of assisting physicians and patients in selecting the best management strategy.

Methods: These guidelines are based on scientific evidence and expert opinion. By summarising and evaluating the best available evidence, recommendations for the diagnosis and treatment of patients have been formulated. The recommendations are graded according to the new ESVS clinical practice guidelines class of recommendation grading system, where the strength (class) of each recommendation is graded from I to III, and the letter A to C marks the level of evidence.

Results: A total of 102 recommendations have been issued on the management of chronic arterial mesenteric ischaemia, median arcuate ligament syndrome, acute arterial mesenteric ischaemia, non-occlusive mesenteric ischaemia, venous mesenteric thrombosis and ischaemia, occlusive disease of the renal arteries and veins, visceral artery aneurysms, and spontaneous isolated dissection of the visceral arteries.

Conclusion: These 2025 ESVS clinical practice guidelines provide comprehensive and up to date advice to physicians and patients on the management of diseases of the mesenteric and renal arteries and veins.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-20-10 at 07:48